Table 2.

Treatment-related adverse events

Toxicity	G3	G4	G5	Total
	N	N	N	N	%
Hypophosphatemia	55	7		62	16.4
Decreased lymphocytes	19	38		57	15.1
Hypocalcemia	25	2		27	7.2
Decreased platelets	24			24	6.4
Hyponatremia	20			20	5.3
Decreased neutrophil counts	13	4		17	4.5
Increased bilirubin	15	1		16	4.2
Decreased white blood cells	15	1		16	4.2
Hypotension	11	1		12	3.2
Fever	7			7	1.9
Hyperglycemia	7			7	1.9
Hypermagnesemia	7			7	1.9
Leukocytosis	7			7	1.9
Hyperkalemia	5	1		6	1.6
Fatigue	6			6	1.6
Diarrhea	5			5	1.3
Hypoalbuminemia	5			5	1.3
Decreased urinary output	5			5	1.3
Thrombotic Thromb Purpura	4			4	1.1
Total events	315	61	1	377	100